MarketInOut Stock Screener Log In | Sign Up

BRAIN Biotech AG

XETRA • Basic Materials • Specialty Chemicals • Quote as of 10/30/2026
BRAIN Biotech AG stock price and volume chart

Company Profile

IndustrySpecialty Chemicals
SectorBasic Materials
ExchangeXETRA
Market Capitalization55.93 mln
Float10.44 mln
Earnings Date01/14/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.04
Reliable

1-Year Forecast

5.75
Transformational upside

Relative Strength

92 / 100
Top performer

Pre-Tax Margin

-23%
Deeply loss-making

ROE

-794
Deeply negative

Business Description

Founded in 1993 and based in Zwingenberg, Germany, BRAIN Biotech AG uses biological processes to create enzymes, microorganisms, and other natural compounds for customers across Europe and the United States. These products serve a wide range of industries, from food and cosmetics to chemicals and waste management. The company also runs an active research program focused on developing new solutions for the life sciences sector.

Key Fundamentals

EPS-0.64
ROE-794
RPS2.11
ROIC-14.01
ROA-15.19
Interest Cover-3.70
EBITDA, mln0.47
EV / EBITDA176
EV / EBIT-18.12
Revenue, mln47.80
EV / Revenue1.73

Quote Details

Last 2.82
Change 0.04 (1.44%)
Open 2.68
Volume 5,081
Turnover 14,328
Average Volume 6,050.29

Financial Ratios

Pre-Tax Profit Margin-23
Current Ratio1.44
Price / Sales1.26

Financial Strength

Altman Z-Score-1.47
Piotroski F-Score 5 / 9
Beneish M-Score-3.04
1-Year Target Price5.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.3% 89 / 100   
1 Month -1.05% 30 / 100   
2 Months 3.68% 72 / 100   
6 Months -13.23% 13 / 100   
1 Year 28.77% 86 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog